CCM
Income statement / Annual
Last year (2023), Concord Medical Services Holdings Limited's total revenue was $537.40 M,
an increase of 13.84% from the previous year.
In 2023, Concord Medical Services Holdings Limited's net income was -$297.66 M.
See Concord Medical Services Holdings Limited’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$537.40 M
|
$472.09 M
|
$485.63 M
|
$223.01 M
|
$198.36 M
|
$190.90 M
|
$330.98 M
|
$455.04 M
|
$616.49 M
|
$606.88 M
|
Cost of Revenue |
$614.01 M |
$624.49 M |
$542.53 M |
$209.93 M |
$214.19 M |
$171.14 M |
$232.98 M |
$286.54 M |
$353.34 M |
$274.56 M |
Gross Profit |
-$76.61 M |
-$152.41 M |
-$56.90 M |
$13.08 M |
-$15.83 M |
$19.76 M |
$98.00 M |
$168.50 M |
$263.15 M |
$332.32 M |
Gross Profit Ratio |
-0.14 |
-0.32 |
-0.12 |
0.06 |
-0.08 |
0.1 |
0.3 |
0.37 |
0.43 |
0.55 |
Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
General & Administrative
Expenses |
$330.08 M
|
$311.16 M
|
$347.75 M
|
$294.82 M
|
$315.13 M
|
$291.85 M
|
$237.65 M
|
$205.91 M
|
$132.95 M
|
$53.58 M
|
Selling & Marketing
Expenses |
$56.30 M
|
$61.48 M
|
$53.68 M
|
$25.76 M
|
$30.24 M
|
$21.72 M
|
$43.61 M
|
$70.09 M
|
$112.82 M
|
$95.10 M
|
Selling, General &
Administrative Expenses |
$386.38 M
|
$372.64 M
|
$401.42 M
|
$320.58 M
|
$345.38 M
|
$313.57 M
|
$281.25 M
|
$276.00 M
|
$245.77 M
|
$148.67 M
|
Other Expenses |
$0.00 |
-$216.61 M |
-$1.22 M |
$6.31 M |
$37.14 M |
$34.21 M |
$2.89 M |
$18.19 M |
$33.62 M |
$2.11 M |
Operating Expenses |
$386.38 M |
$372.64 M |
$401.42 M |
$320.58 M |
$345.38 M |
$313.57 M |
$281.25 M |
$276.00 M |
$245.77 M |
$148.67 M |
Cost And Expenses |
$1.00 B |
$997.13 M |
$943.95 M |
$530.51 M |
$559.57 M |
$484.71 M |
$514.23 M |
$562.54 M |
$599.10 M |
$423.23 M |
Interest Income |
$10.83 M |
$10.02 M |
$5.89 M |
$8.44 M |
$9.17 M |
$14.17 M |
$12.08 M |
$27.98 M |
$22.45 M |
$21.21 M |
Interest Expense |
$165.67 M |
$120.36 M |
$73.79 M |
$81.36 M |
$28.70 M |
$46.23 M |
$89.96 M |
$89.33 M |
$53.21 M |
$53.47 M |
Depreciation &
Amortization |
$128.45 M
|
$132.81 M
|
$104.08 M
|
$80.30 M
|
$56.35 M
|
$54.63 M
|
$94.71 M
|
$129.01 M
|
$158.34 M
|
$201.68 M
|
EBITDA |
-$313.75 M
|
-$586.73 M
|
-$351.37 M
|
-$255.98 M
|
-$296.56 M
|
-$211.56 M
|
-$96.04 M
|
$13.74 M
|
$67.87 M
|
$430.80 M
|
EBITDA Ratio |
-0.58 |
-1.23 |
-0.68 |
-0.93 |
-1.33 |
-1.11 |
-0.22 |
0.15 |
0.11 |
0.36 |
Operating Income Ratio
|
-0.86
|
-1.11
|
-0.94
|
-1.38
|
-2.2
|
-1.57
|
-0.64
|
-0.37
|
-0.01
|
0.3
|
Total Other
Income/Expenses Net |
-$92.61 M
|
-$314.85 M
|
-$70.92 M
|
-$125.65 M
|
$46.22 M
|
$74.00 M
|
-$42.04 M
|
-$35.97 M
|
$489,000.00
|
-$8.00 M
|
Income Before Tax |
-$555.59 M |
-$839.90 M |
-$529.24 M |
-$441.65 M |
-$391.08 M |
-$225.25 M |
-$253.90 M |
-$204.60 M |
-$5.25 M |
$175.65 M |
Income Before Tax Ratio
|
-1.03
|
-1.78
|
-1.09
|
-1.98
|
-1.97
|
-1.18
|
-0.77
|
-0.45
|
-0.01
|
0.29
|
Income Tax Expense |
-$24.57 M |
-$70.91 M |
-$6.57 M |
-$37.62 M |
-$38.99 M |
$34.05 M |
$31.79 M |
$60.49 M |
$74.03 M |
$80.85 M |
Net Income |
-$297.66 M |
-$489.66 M |
-$820.62 M |
-$669.91 M |
-$552.53 M |
-$359.23 M |
-$284.32 M |
-$261.87 M |
-$78.30 M |
$99.23 M |
Net Income Ratio |
-0.55 |
-1.04 |
-1.69 |
-3 |
-2.79 |
-1.88 |
-0.86 |
-0.58 |
-0.13 |
0.16 |
EPS |
-68.14 |
-112.09 |
-187.85 |
-153.35 |
-127.27 |
-82.83 |
-65.57 |
-60.14 |
-17.46 |
22.08 |
EPS Diluted |
-68.14 |
-112.09 |
-187.85 |
-153.35 |
-127.27 |
-82.83 |
-65.57 |
-60.14 |
-17.46 |
21.95 |
Weighted Average Shares
Out |
$4.37 M
|
$4.37 M
|
$4.37 M
|
$4.37 M
|
$4.34 M
|
$4.34 M
|
$4.34 M
|
$4.35 M
|
$4.48 M
|
$4.52 M
|
Weighted Average Shares
Out Diluted |
$4.37 M
|
$4.37 M
|
$4.37 M
|
$4.37 M
|
$4.34 M
|
$4.34 M
|
$4.34 M
|
$4.35 M
|
$4.48 M
|
$4.51 M
|
Link |
|
|
|
|
|
|
|
|
|
|